We have a very successful model for our early phase centers including a dedicated recruitment team to ensure your study is started, and completed on time. Celerion’s infused culture of quality is evident in all of our compliance systems, processes and personnel across the company and is inherent in every program. We focus on developing efficient processes with real-time quality control to ensure delivery of high-quality, accurate data. You have real-time access to your data through ClinQuick®, our proprietary data collection system. In addition, our onsite bioanalysis capabilities provide precise and safe dose escalation in as little as seven days, enabling you to make adjustments safely, quickly and accurately.
Click here for a full description of the types of studies, we have performed.
Celerion is fully accredited from the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for our clinical facilities in Lincoln NE and Phoenix AZ which demonstrates our leadership in reaching the highest standards and protection for human subjects in our clinical studies.
Our Belfast clinic covers all your early phase development needs through our comprehensive early clinical research services. It offers 78 beds across four clinical wards that are customizable to support both large numbers of healthy participants and small groups of patients for early clinical research studies. You benefit from faster access to target patient populations, specialists and techniques in Phase I & II studies, expediting decision making, and speeding up the path to clinical Proof-of-Concept (CPoC). Celerion’s state-of-the-art Belfast facility is a MHRA-accredited clinic and a member of the UK’s Translational Research Partnership in Respiratory. Celerion is the global leader in respiratory studies and a recognized Center of Excellence for respiratory medicine including mild to moderate and severe asthmatics, COPD and cystic fibrosis.
The Lincoln clinic is one of the most established Phase I clinics in the industry, and offers a complete array of early clinical research services including an onsite bioanalysis laboratory, comprehensive PK/PD, statistics and data management. Lincoln’s onsite bioanalysis laboratory allows for 48-hour data turnaround, giving you faster access to data to make go/no-go decisions. For even complex studies, Celerion will help design and complete your study faster.With 224 beds, 24 in-hospital beds, you have access to a number of specialized services including the efficient execution of micro tracer and micro dosing studies, conduct of radio-labelled compound and ADME studies. The clinic is fully GCP/GLP compliant while the clinical lab is CLIA licensed and CAP certified and has earned the “Laboratory of Distinction” from CAP. The onsite pharmacy is DEA licensed.
Our state-of-the-art clinic in Phoenix offers comprehensive clinical capabilities and a full clinical laboratory. With 300 beds, including 65 intensive care beds, the clinic has one of the largest early phase clinical bed capacities in the United States. Celerion’s Phoenix facility has been in operation over 25 years. With this depth of knowledge and experience, Celerion offers creative solutions for yourprograms to optimize success. We have completed over 300 studies in the last five years: including PK, bioavailability, drug-drug interaction and first-in-human. We provide speed of data entry and accuracy of reporting within 48 hours of collection through ClinQuick®, paper as well as EDC systems. Our Phoenix facility is a market leader in cardiovascular safety services and has a proven record in efficiently conducting ophthalmic studies to save time and cost.